THERAVECTYS
THERAVECTYS develops a platform for the PREvention and treatment of cancers and other infectious diseases and conditions.
THERAVECTYS has raised €24M across 3 funding rounds from 2 investors, most recently a round in Jan 2015. Based in Paris, France; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€24M
€24,080,000
Funding rounds
3
Investors
2
distinct backers
Active since
2012-09
latest 2015-01
Funding by year
EUR raised per yearTHERAVECTYS — funding by year — interactive chart.
Data table
| THERAVECTYS — funding by year | |
|---|---|
| 2012 | €7.5M |
| 2013 | €15M |
| 2014 | €1.9M |
Signals
High confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-01-01 | Other | €1.9M | Bpifrance | View deal → |
| 2013-10-01 | Other | €15M | — | View deal → |
| 2012-09-01 | Other | €7.5M | John PIETERS | View deal → |
Investors
2Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData